Conference Paper: HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome

File Download

re01.htm

Links for fulltext
(May Require Subscription)

Publisher Website: 10.1002/hep.23990
Find via

Supplementary

Citations:
- Scopus:
- Web of Science:
- PubMed Central:
Item Statistics (The Hub)
Appears in Collections:
- Medicine: Conference papers

Title	HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome
Authors	Seto, WK Lai, CL Fung, J Wong, D Yuen, JCH Hung, IFN Yuen, MF
Keywords	Medical sciences Gastroenterology
Issue Date	2010
Publisher	John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation	The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456 [How to Cite?] DOI: http://dx.doi.org/10.1002/hep.23990
Abstract	BACKGROUND: The significance of serum week 12 HBV DNA in predicting long-term outcomes of chronic hepatitis B (CHB) patients on telbivudine is not yet defined. Methods: We determined the cumulative rates of HBeAg …
ISSN	0270-9139 2011 Impact Factor: 11.665 2011 SCImago Journal Rankings: 1.278
DOI	http://dx.doi.org/10.1002/hep.23990

DC Field	Value
dc.contributor.author	Seto, WK
dc.contributor.author	Lai, CL
dc.contributor.author	Fung, J
dc.contributor.author	Wong, D
dc.contributor.author	Yuen, JCH
dc.contributor.author	Hung, IFN
dc.contributor.author	Yuen, MF
dc.date.accessioned	2011-08-26T14:33:10Z
dc.date.available	2011-08-26T14:33:10Z
dc.date.issued	2010
dc.description.abstract	BACKGROUND: The significance of serum week 12 HBV DNA in predicting long-term outcomes of chronic hepatitis B (CHB) patients on telbivudine is not yet defined. Methods: We determined the cumulative rates of HBeAg …
dc.description.nature	link_to_OA_fulltext
dc.description.other	The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456
dc.identifier.citation	The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456 [How to Cite?] DOI: http://dx.doi.org/10.1002/hep.23990
dc.identifier.doi	http://dx.doi.org/10.1002/hep.23990
dc.identifier.epage	547A
dc.identifier.hkuros	190373
dc.identifier.issn	0270-9139 2011 Impact Factor: 11.665 2011 SCImago Journal Rankings: 1.278
dc.identifier.issue	suppl. S1
dc.identifier.openurl
dc.identifier.spage	547A
dc.identifier.uri	http://hdl.handle.net/10722/137774
dc.identifier.volume	52
dc.language	eng
dc.publisher	John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
dc.relation.ispartof	Hepatology
dc.rights	Hepatology. Copyright © John Wiley & Sons, Inc.
dc.subject	Medical sciences
dc.subject	Gastroenterology
dc.title	HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome
dc.type	Conference_Paper

<?xml encoding="utf-8" version="1.0"?><item><contributor.author>Seto, WK</contributor.author><contributor.author>Lai, CL</contributor.author><contributor.author>Fung, J</contributor.author><contributor.author>Wong, D</contributor.author><contributor.author>Yuen, JCH</contributor.author><contributor.author>Hung, IFN</contributor.author><contributor.author>Yuen, MF</contributor.author><date.accessioned>2011-08-26T14:33:10Z</date.accessioned><date.available>2011-08-26T14:33:10Z</date.available><date.issued>2010</date.issued><identifier.citation>The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456</identifier.citation><identifier.issn>0270-9139</identifier.issn><identifier.uri>http://hdl.handle.net/10722/137774</identifier.uri><description.abstract>BACKGROUND: The significance of serum week 12 HBV DNA in predicting long-term outcomes of chronic hepatitis B (CHB) patients on telbivudine is not yet defined. Methods: We determined the cumulative rates of HBeAg &#8230;</description.abstract><language>eng</language><publisher>John Wiley &amp; Sons, Inc. The Journal&apos;s web site is located at http://www.hepatology.org/</publisher><relation.ispartof>Hepatology</relation.ispartof><rights>Hepatology. Copyright &#169; John Wiley &amp; Sons, Inc.</rights><subject>Medical sciences</subject><subject>Gastroenterology</subject><title>HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome</title><type>Conference_Paper</type><identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0270-9139&amp;volume=52&amp;issue=Suppl. S1&amp;spage=547A, abstract no. 456&amp;epage=&amp;date=2010&amp;atitle=HBV+DNA+levels+after+12+weeks+of+telbivudine+treatment+in+chronic+hepatitis+B+predicts+long-term+outcome</identifier.openurl><description.nature>link_to_OA_fulltext</description.nature><identifier.doi>10.1002/hep.23990</identifier.doi><identifier.hkuros>190373</identifier.hkuros><identifier.volume>52</identifier.volume><identifier.issue>suppl. S1</identifier.issue><identifier.spage>547A</identifier.spage><identifier.epage>547A</identifier.epage><description.other>The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456</description.other><bitstream.url>http://hub.hku.hk/bitstream/10722/137774/1/re01.htm</bitstream.url></item>